123 related articles for article (PubMed ID: 16236703)
1. Identification and characterization of amino acid residues essential for the active site of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Staphylococcus aureus.
Nishida S; Kurokawa K; Matsuo M; Sakamoto K; Ueno K; Kita K; Sekimizu K
J Biol Chem; 2006 Jan; 281(3):1714-24. PubMed ID: 16236703
[TBL] [Abstract][Full Text] [Related]
2. A structural variation for MurB: X-ray crystal structure of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB).
Benson TE; Harris MS; Choi GH; Cialdella JI; Herberg JT; Martin JP; Baldwin ET
Biochemistry; 2001 Feb; 40(8):2340-50. PubMed ID: 11327854
[TBL] [Abstract][Full Text] [Related]
3. Isolation and mutation site determination of the temperature-sensitive murB mutants of Staphylococcus aureus.
Matsuo M; Kurokawa K; Nishida S; Li Y; Takimura H; Kaito C; Fukuhara N; Maki H; Miura K; Murakami K; Sekimizu K
FEMS Microbiol Lett; 2003 May; 222(1):107-13. PubMed ID: 12757953
[TBL] [Abstract][Full Text] [Related]
4. Characterization of NADP+ binding to perdeuterated MurB: backbone atom NMR assignments and chemical-shift changes.
Constantine KL; Mueller L; Goldfarb V; Wittekind M; Metzler WJ; Yanchunas J; Robertson JG; Malley MF; Friedrichs MS; Farmer BT
J Mol Biol; 1997 Apr; 267(5):1223-46. PubMed ID: 9150408
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.
Eniyan K; Dharavath S; Vijayan R; Bajpai U; Gourinath S
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):397-406. PubMed ID: 29203374
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from the Gram-positive pathogen Streptococcus pneumoniae.
Sylvester DR; Alvarez E; Patel A; Ratnam K; Kallender H; Wallis NG
Biochem J; 2001 Apr; 355(Pt 2):431-5. PubMed ID: 11284731
[TBL] [Abstract][Full Text] [Related]
7. (E)-enolbutyryl-UDP-N-acetylglucosamine as a mechanistic probe of UDP-N-acetylenolpyruvylglucosamine reductase (MurB).
Lees WJ; Benson TE; Hogle JM; Walsh CT
Biochemistry; 1996 Feb; 35(5):1342-51. PubMed ID: 8634262
[TBL] [Abstract][Full Text] [Related]
8. Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates.
Chen MW; Lohkamp B; Schnell R; Lescar J; Schneider G
PLoS One; 2013; 8(6):e66936. PubMed ID: 23805286
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary X-ray analysis of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Staphylococcus aureus.
Harris MS; Herberg JT; Cialdella JI; Martin JP; Benson TE; Choi GH; Baldwin ET
Acta Crystallogr D Biol Crystallogr; 2001 Jul; 57(Pt 7):1032-5. PubMed ID: 11418774
[TBL] [Abstract][Full Text] [Related]
10. The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls.
Benson TE; Walsh CT; Hogle JM
Structure; 1996 Jan; 4(1):47-54. PubMed ID: 8805513
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous, high-throughput-compatible, fluorescence intensity-based assay for UDP-N-acetylenolpyruvylglucosamine reductase (MurB) with nanomolar product detection.
Shapiro AB; Livchak S; Gao N; Whiteaker J; Thresher J; Jahić H; Huang J; Gu RF
J Biomol Screen; 2012 Mar; 17(3):327-38. PubMed ID: 22068704
[TBL] [Abstract][Full Text] [Related]
12. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques.
Kumar V; Saravanan P; Arvind A; Mohan CG
J Mol Model; 2011 May; 17(5):939-53. PubMed ID: 20614148
[TBL] [Abstract][Full Text] [Related]
13. 3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria.
Yang Y; Severin A; Chopra R; Krishnamurthy G; Singh G; Hu W; Keeney D; Svenson K; Petersen PJ; Labthavikul P; Shlaes DM; Rasmussen BA; Failli AA; Shumsky JS; Kutterer KM; Gilbert A; Mansour TS
Antimicrob Agents Chemother; 2006 Feb; 50(2):556-64. PubMed ID: 16436710
[TBL] [Abstract][Full Text] [Related]
14. Overexpression, purification, and mechanistic study of UDP-N-acetylenolpyruvylglucosamine reductase.
Benson TE; Marquardt JL; Marquardt AC; Etzkorn FA; Walsh CT
Biochemistry; 1993 Mar; 32(8):2024-30. PubMed ID: 8448160
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Thermus caldophilus.
Kim MK; Cho MK; Song HE; Kim D; Park BH; Lee JH; Kang GB; Kim SH; Im YJ; Lee DS; Eom SH
Proteins; 2007 Feb; 66(3):751-4. PubMed ID: 17120230
[No Abstract] [Full Text] [Related]
16. Kinetic characterization of wild-type and S229A mutant MurB: evidence for the role of Ser 229 as a general acid.
Benson TE; Walsh CT; Massey V
Biochemistry; 1997 Jan; 36(4):796-805. PubMed ID: 9020777
[TBL] [Abstract][Full Text] [Related]
17. Steady-state kinetic mechanism of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase.
Dhalla AM; Yanchunas J; Ho HT; Falk PJ; Villafranca JJ; Robertson JG
Biochemistry; 1995 Apr; 34(16):5390-402. PubMed ID: 7727397
[TBL] [Abstract][Full Text] [Related]
18. In silico identification, synthesis and biological evaluation of novel tetrazole inhibitors of MurB.
Hrast M; Jukič M; Patin D; Tod J; Dowson CG; Roper DI; Barreteau H; Gobec S
Chem Biol Drug Des; 2018 Jun; 91(6):1101-1112. PubMed ID: 29363274
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary X-ray crystallographic studies of UDP-N-acetylenolpyruvylglucosamine reductase.
Benson TE; Walsh CT; Hogle JM
Protein Sci; 1994 Jul; 3(7):1125-7. PubMed ID: 7920261
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]